Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2000, p. 1778-1782, Vol. 44, No. 7
Departamento de Biotecnología
Microbiana, Centro Nacional de Biotecnología, CSIC, Campus
UAM, Cantoblanco, 28049-Madrid, Spain
Received 3 December 1999/Returned for modification 22 February
2000/Accepted 11 April 2000
A cluster of genes involved in antibiotic and heavy metal
resistance has been characterized from a clinical isolate of the gram-negative bacterium Stenotrophomonas maltophilia. These
genes include a macrolide phosphotransferase (mphBM) and a
cadmium efflux determinant (cadA), together with the gene
cadC coding for its transcriptional regulator. The
cadC cadA region is flanked by a truncated
IS257 sequence and a region coding for a bin3
invertase. Despite their presence in a gram-negative bacterium, these
genetic elements share a common gram-positive origin. The possible
origin of these determinants as a remnant composite transposon as well as the role of gene transfer between gram-positive and gram-negative bacteria for the acquisition of antibiotic resistance determinants in
chronic, mixed infections is discussed.
Stenotrophomonas
maltophilia has emerged in the last few years as an important
nosocomial opportunistic pathogen. This bacterial species has been
associated with different diseases, mainly in severely debilitated or
immunosuppressed individuals (reviewed by Denton and Kerr
[8]), as well as in the last stages of cystic fibrosis
(12). Infections by S. maltophilia are difficult
to treat (21, 23) due to the intrinsic antibiotic resistance of this bacterial species (2, 10). A combination of reduced permeability (31) and expression of efflux pump(s) (1,
33) might account at least in part for S. maltophilia
intrinsic resistance to drugs. In addition to these mechanisms,
antibiotic-inactivating enzymes such as metallo-beta-lactamases and
cephalosporinases (19, 27, 29, 30) or, more recently,
aminoglycoside-modifying enzymes (13), have been described
to be encoded by S. maltophilia. Like other gram-negative
bacilli, S. maltophilia is weakly susceptible to
erythromycin. Besides a reduced permeability to the drug, S. maltophilia can pump out the antibiotic through a multidrug efflux determinant (A.A. and J.L.M., submitted for publication). In an attempt
to further characterize the mechanisms involved in the reduced
susceptibility to erythromycin in this bacterial species, we have
cloned a DNA region capable of conferring erythromycin resistance to a
hypersusceptible Escherichia coli strain. Sequencing of this
region has demonstrated the presence of isoforms of genes previously
found in Staphylococcus aureus and involved in resistance to
erythromycin (mphBM) and cadmium (cadC and
cadA). These genes are surrounded by a bin3
invertase (25) and a truncated IS257 sequence
(20). The structure and G+C content of this DNA region suggests a gram-positive origin for these determinants. Gene transfer between gram-positive and gram-negative bacteria is well documented (7). We demonstrate here that the occurrence of such a
transfer might be a powerful mechanism for acquiring antibiotic
resistance genes in nosocomial pathogens such as S. maltophilia.
Bacterial strains and growth conditions.
S.
maltophilia D457R is a spontaneous multiresistant derivative of
the clinical isolate S. maltophilia D457 (1).
E. coli KZM120 (14) contains an acrAB
null mutation
( Construction and screening of a DNA library.
Chromosomal DNA
for library construction was extracted from S. maltophilia
D457R as described previously (4). The obtained DNA was
partially digested with Bsp1431 (MBI Fermentas, Vilnius, Lithuania), and fragments of 5 to 9 kb were isolated upon
centrifugation on a 10 to 40% (wt/vol) sucrose gradient. DNA fragments
were ligated to an alkaline phosphatase-treated
BamHI-linearized plasmid pUC19 (26). E. coli KZM120 was electroporated with the ligation mixture, and
transformants were selected on medium containing erythromycin, ampicillin, and kanamycin. Preparation and analysis of plasmid DNA was
performed by standard methods as described previously (26).
Drug susceptibility measurements.
The MICs of erythromycin
were determined in Mueller-Hinton medium (3) by E-Test (AB
Biodisk, Solna, Sweden), according to the manufacturer's instructions.
DNA sequencing.
Automatic sequencing (Perkin-Elmer Gene
Sequencer ABI310) of both strands of the DNA fragment contained in the
plasmid pERY1 was carried out by primer walking. Analysis of the
sequences was performed with the aid of Wisconsin Package version 9.1 (Genetics Computer Group, Madison, Wis.).
Southern blotting.
Chromosomal DNA from S. maltophilia D457 and D457R was treated with EcoRI (MBI
Fermentas), electrophoresed on 0.7% agarose gel and transferred to
Hybond-N (Amersham) as described earlier (26). PCR.
An internal fragment of 140 bp from the
mphBM gene was amplified by PCR using primer 1 (5'-CCAACCTCAAACAATCTCATTG-3') and primer 2 (5'-GCTGCGGGTTTACCTGTAAG-3'). Reaction mixture (50 µl) contained 0.2 mM concentrations of each deoxynucleotide (dCTP, dTTP,
dGTP, and dATP), 0.5 µM concentrations of each primer, 1.5 mM
MgCl2, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 100 ng of
template DNA, and 1.0 U of Taq DNA polymerase. The mixture
was heated for 90 s at 94°C, followed by 35 cycles of 30 s
at 94°C, 60 s at 60°C, and a 90-s extension step at 72°C
and, finally, one 10-min extension cycle at 72°C before the end of
the reaction. PCR products were analyzed by electrophoresis on an 1.6%
agarose gel. A 100-bp DNA ladder (BioLabs) was used as the molecular
size marker. Chromosomal DNAs from S. maltophilia D457R
obtained with 1 year of difference were used as templates. The more
recent DNA chromosomal preparation was obtained using the Genome DNA
Kit (Bio 101).
Nucleotide sequence accession number.
The nucleotide
sequence of the ERY1 region has been assigned GenBank accession number
AJ251015.
Cloning of an erythromycin resistance gene from S. maltophilia D457R.
We have previously characterized an
S. maltophilia spontaneous mutant (D457R) which shows an
enhanced resistance to several different antibiotics (1),
one of which is erythromycin. The MIC of erythromycin was 32 µg/ml
for the wild-type strain S. maltophilia D457 and >256
µg/ml for the mutant strain S. maltophilia D457R. To clone
the gene(s) responsible for erythromycin resistance in S. maltophilia D457R, we constructed a library in the plasmid pUC19
(see Materials and Methods) using as a receptor E. coli strain KZM120, which lacks the efflux pump determinant acrAB
(14). Deletion of this multidrug resistance operon reduced
the MIC of erythromycin from 16 to 2 µg/ml, making KZM120 a suitable
strain for cloning macrolide resistance genes. The library was
seeded onto plates containing erythromycin (6 µg/ml) as the selective agent. A single colony capable of growth under these conditions was
isolated. Plasmid DNA (hereafter named pERY1) was obtained from such a
clone, E. coli KZM120 was retransformed with this DNA
preparation, and transformants were selected either in plates containing ampicillin at 200 µg/ml (the antibiotic selection marker of plasmid pUC19) or in plates containing erythromycin at 6 µg/ml. The number of transformants that grew under both selective conditions was the same. Thus, the 5,451-bp DNA fragment present in pERY1 carries
a determinant for erythromycin resistance. Further confirmation was obtained from the analysis of susceptibility to erythromycin of strains either containing or not containing pERY1. As previously stated, the MIC of erythromycin for E. coli KZM120 is 2 µg/ml, and the same value was obtained for E. coli
KZM120(pUC19). However, this value increased to reach 32 µg/ml
for E. coli KZM120(pERY1), confirming that this plasmid
contains an erythromycin resistance determinant. To assure that this
DNA fragment is present in the genome of S. maltophilia
D457R, PCR analysis was performed with chromosomal DNA obtained from
S. maltophilia D457R by two different methods. As shown in
Fig. 1a, a band with the predicted
molecular size was amplified from both DNA preparations. Further
confirmation of the presence of the ERY1 fragment in the genomes of
S. maltophilia D457 and D457R was obtained by Southern blot
analysis of restriction digests of chromosomal DNA from both strains
using an internal probe from plasmid pERY1. The presence of
hybridization signal bands with a molecular size of 4.4 kbp (Fig. 1b)
indicated that the DNA fragment cloned in pERY1 is present in the
genomes of both S. maltophilia D457 and S. maltophilia D457R. The genetic structure of this DNA region is
shown in Fig. 2. The G+C content of this
DNA region (35.1%) strongly suggests a gram-positive origin for this
gene cluster.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Stenotrophomonas maltophilia D457R Contains a Cluster
of Genes from Gram-Positive Bacteria Involved in Antibiotic and
Heavy Metal Resistance
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
acrAB::Tn903Kanr) that
renders it drug hypersusceptible and was a kind gift from Dzwokai Ma.
Bacterial strains were grown in Luria-Bertani medium (3) at
37°C with shaking, unless indicated otherwise. For selection purposes, medium was supplemented with ampicillin (200 µg/ml), kanamycin (25 µg/ml), and erythromycin (6 µg/ml).
DNA/HindIII (MBI Fermentas) was used as the
molecular size marker. Membranes were subjected to overnight
hybridization and subsequent washings under stringent conditions at
60°C with an mphBM probe obtained by PCR from pERY1 (see
below). The obtained PCR product was purified with Micro Bio-Spin
chromatography columns (Bio-Rad), labeled with
[
-32P]dCTP using the DNA Labelling Kit-dCTP
(Pharmacia Biotech), according to the manufacturer's instructions, and
added to the hybridization buffer.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (26K):
[in a new window]
FIG. 1.
Analysis of the presence of mphBM in the
genome of S. maltophilia D457R. The presence of this gene in
the genome of S. maltophilia was analyzed by two different
methods. (a) Results of PCR amplification with primers specific for
mphBM. M, molecular size markers. Top, 200 bp; bottom, 100 bp; +, positive control, with amplification using the plasmid pERY1 as
the template; lanes 1 and 2, amplification with two different genomic
DNA preparations from S. maltophilia D457 as templates. A
band with the predicted molecular size (144 bp) was amplified from both
DNAs.
, negative control. (b) Results of the hybridization of
EcoRI-digested genomic DNAs from S. maltophilia
D457 (lane 1) and D457R (lane 2) with an internal probe specific for
the detection of mphBM. In both cases, a hybridization
signal corresponding to a 4.2-kbp DNA fragment was detected. M,
molecular size markers. Bars, from the top: 23, 9.4, 6.5, 4.4, 2.3, and
2.0 kbp.

View larger version (14K):
[in a new window]
FIG. 2.
Organization of the ERY1 region from S. maltophilia D457. The genetic structure of this region, as well as
its relationship with some other previously analyzed sequences, is
shown. The structure of ERY1 is shown in the middle of the figure.
White arrows indicate the localization and orientation of the ORFs of
the region. All of them present homologies of >90% with the
previously characterized sequences shown in the figure. Black arrows
indicate the localization and orientation of regions with homologies of
>90% with sequences deposited at DNA data banks but which do not
contain any ORFs. Gray arrows indicate the position and orientation of
regions with homologies with sequences deposited at DNA data banks of
<90%.
mphBM gene.
Sequencing of the DNA fragment and
further analysis demonstrated the presence of a gene that is nearly
identical to the previously described mphBM gene from
S. aureus. mphBM encodes the synthesis of a macrolide
phosphotranferase (15), and homologs for this gene have been
described in E. coli (16, 17) and
Streptomyces rochei (9). The homology of these
genes ranges from 30 to 50%; however, in the case of S. maltophilia, the homology is 98.2% at the DNA level and 99.7%
(with 98.3% identity) at the protein level compared with
mphBM (Table 1). This
extremely high homology indicates that the gene mphBM of
S. maltophilia has been recently acquired from S. aureus and is just an isoform of the S. aureus gene. Erythromycin MICs were determined for E. coli
KM120(pUC19) and E. coli KM120(pERY1). The MIC values were 2 and 32 µg/ml, respectively. The fact that the MIC of erythromycin
increases in the presence of this gene in E. coli KZM120
indicates that it is functionally active in this bacterial species in
spite of its possible gram-positive origin.
|
bin3 gene. Analysis of the sequence downstream from mphBM indicates the presence of a DNA region highly homologous (Table 1) to a central region of the transposon Tn552 from S. aureus. This region comprises the gene bin3, a divergent member of the resolvase-invertase family (25). The homologous region from S. maltophilia includes not only the bin3 isoform but also a palindromic sequence upstream from the open reading frame (ORF). A 107-bp sequence with an unknown function that is present 828 bp upstream from bin3 in Tn552 is also present, although it is inverted in this DNA region of S. maltophilia (Fig. 1).
cadC and cadA genes. The 107-bp region, present in pERY1 and upstream from bin3 in Tn552 is also present upstream from the cadC gene in the plasmid pI258 (18) from S. aureus. cadC (32) is a regulator of the expression of cadA, a gene involved in the efflux of cadmium by S. aureus carrying the plasmid pI258 (18). Isoforms of both genes are also present, in the same order as in S. aureus in S. maltophilia (Fig. 1). Downstream from cadA, the homology between S. aureus and S. maltophilia is maintained to the end of the published S. aureus sequence, the only difference being a 103-bp internal region which is present in S. aureus and not in S. maltophilia (Fig. 1).
IS257. The region downstream from the cadA ORF is highly homologous, not only to the surrounding cadA sequence from the S. aureus plasmid pI258 but also to the insertion sequence IS257. This indicates that an IS257 sequence is probably downstream from cadA in pI258. In the case of S. maltophilia D457, the homology includes one of the inverted repeats and part of the transposase gene. Only the half-carboxy-terminal part of the gene (amino acids 108 to 218) is present, and it is truncated by an additional 133-bp sequence (Fig. 1) which presents a 64.5% homology with the region from residue 3710 to residue 3840 from the IS257-containing plasmid pSK156 (20). The function of this region is unknown.
| |
DISCUSSION |
|---|
|
|
|---|
S. maltophilia is an opportunistic pathogen intrinsically resistant to several antibiotics. Some antibiotic resistance genes have been characterized from this bacterial species and, in most cases, they can be considered indigenous (and even housekeeping) genes more than acquired antibiotic resistance genes (13, 19, 27). In our work, we present evidence that S. maltophilia D457 has acquired a cluster of antibiotic and heavy metal resistance genes from gram-positive bacteria. Most of these genes are isoforms of genes previously found in S. aureus plasmids. Only, a 360-bp DNA region did not have an S. aureus counterpart in current DNA databases. This region was homologous with a sequence from Clostridium perfringens with unknown function. However, the fact that the homology of this region was <60%, indicates that it is not an isoform of a gene present in C. perfringens but only a homolog. Whether the organism from which the ERY1 DNA region has been transferred to S. maltophilia also contains the same homolog of this C. perfringens DNA is a matter of speculation.
The combination of ERY1 genes in the same DNA region has not yet been described. The genetic elements present in pERY1 were first characterized from S. aureus strains isolated at different geographic locations (in Japan and the United States) and in different years. The gram-positive origin of these genes is reinforced by the G+C content (Table 1). Overall, this value is 35.1%, a level closely similar to that for the genomes of gram-positive bacteria such as S. aureus and quite different from the 63 to 67.5% reported for S. maltophilia (8). IS257 is an insertion sequence ubiquitously found in the chromosome and plasmids of S. aureus (28), whereas its presence is uncommon in other bacterial species.
DNA exchange between gram-positive and gram-negative bacteria has been described; however, this is the first time in which this transfer has been documented for S. maltophilia. The organization of the sequenced region strongly suggests its origin as a transposon-like structure in which several insertion events might have occurred. In this way, the presence of a truncated IS257 sequence points to the possible insertion of another genetic element in this region. This complex structure resembles those found in the composite transposons from gram-positive bacteria (5, 6, 24). The strong similarities but also the differences (for instance, the deletion downstream of cadA from S. aureus) of these genetic elements with respect to their gram-positive counterparts indicate that several different recombination events have occurred to yield this genetic patchwork. Since the genetic elements of this region (Table 1) are characteristic of gram-positive bacteria, we think that these recombination events occurred before the acquisition of this DNA region by S. maltophilia.
For this transfer to occur, bacteria must share the same environment. This situation is common in the case of mixed infections and might be relevant in chronic infections such as cystic fibrosis. In fact, S. maltophilia D457 (the parental strain of D457R) is a clinical isolate from the sputum of a cystic fibrosis patient. Since S. aureus is frequently encountered in the lungs of cystic fibrosis patients (11), the DNA determinants present in the DNA region characterized in the present work might have been acquired from a strain of this bacterial species infecting the same individual as S. maltophilia D457. Alternatively, transfer of these determinants might have occurred in environmental conditions between S. maltophilia and gram-positive organisms such as Bacillus spp., which share the same environmental habitat.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dzwokai Ma for the gift of E. coli KZM120 and A. Varas for technical assistance.
This research was supported in part by grant 08.2/022/98 from Comunidad Autónoma de Madrid. A. Alonso is a recipient of a fellowship from Gobierno Vasco. P. Sanchez is a recipient of a fellowship from Ministerio de Educación y Cultura.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Departamento de Biotecnología Microbiana, Centro Nacional de Biotecnología, CSIC, Campus UAM, Cantoblanco, 28049 Madrid, Spain. Phone: (341) 5854551. Fax: (341) 5854506. E-mail: jlmtnez{at}cnb.uam.es.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alonso, A., and J. L. Martínez. 1997. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41:1140-1142[Abstract]. |
| 2. | Arpi, M., M. A. Victor, I. Mortensen, A. Gottschau, and B. Bruun. 1996. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods. APMIS 104:108-114[Medline]. |
| 3. | Atlas, R. M. 1993. Handbook of microbiological media. CRC Press, Inc., London, England. |
| 4. | Bagdasarian, M., and M. M. Bagdasarian. 1994. Gene cloning and expression, p. 406-417. In P. Gerhardt, R. G. E. Murray, W. A. Wood, and N. R. Krieg (ed.), Methods for general and molecular bacteriology. American Society for Microbiology, Washington, D.C. |
| 5. | Bonafede, M. E., L. L. Carias, and L. B. Rice. 1997. Enterococcal transposon Tn5384: evolution of a composite transposon through cointegration of enterococcal and staphylococcal plasmids. Antimicrob. Agents Chemother. 41:1854-1858[Abstract]. |
| 6. |
Byrne, M. E.,
M. T. Gillespie, and R. A. Skurray.
1990.
Molecular analysis of a gentamicin resistance transposonlike element on plasmids isolated from North American Staphylococcus aureus strains.
Antimicrob. Agents Chemother.
34:2106-2113 |
| 7. |
Courvalin, P.
1994.
Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria.
Antimicrob. Agents Chemother.
38:1447-1451 |
| 8. |
Denton, M., and K. G. Kerr.
1998.
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.
Clin. Microbiol. Rev.
11:57 |
| 9. |
Fernandez Moreno, M. A.,
C. Vallin, and F. Malpartida.
1997.
Streptothricin biosynthesis is catalyzed by enzymes related to nonribosomal peptide bond formation.
J. Bacteriol.
179:6929-6936 |
| 10. | Garrison, M. W., D. E. Anderson, D. M. Campbell, K. C. Carroll, C. L. Malone, J. D. Anderson, R. J. Hollis, and M. A. Pfaller. 1996. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40:2859-2864[Abstract]. |
| 11. |
Gilligan, P. H.
1991.
Microbiology of airway disease in patients with cystic fibrosis.
Clin. Microbiol. Rev.
4:35-51 |
| 12. |
Karpati, F.,
A. S. Malmborg,
H. Alfredsson,
L. Hjelte, and B. Strandvik.
1994.
Bacterial colonisation with Xanthomonas maltophilia a retrospective study in a cystic fibrosis patient population.
Infection
22:258-263[CrossRef][Medline].
|
| 13. |
Lambert, T.,
M. C. Ploy,
F. Denis, and P. Courvalin.
1999.
Characterization of the chromosomal aac(6')-Iz gene of Stenotrophomonas maltophilia.
Antimicrob. Agents Chemother.
43:2366-2371 |
| 14. | Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16:45-55[CrossRef][Medline]. |
| 15. | Matsuoka, M., K. Endou, H. Kobayashi, M. Inoue, and Y. Nakajima. 1998. A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol Lett. 167:221-227[CrossRef][Medline]. |
| 16. | Noguchi, N., A. Emura, H. Matsuyama, K. O'Hara, M. Sasatsu, and M. Kono. 1995. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2'-phosphotransferase I in Escherichia coli. Antimicrob. Agents Chemother. 39:2359-2363[Abstract]. |
| 17. | Noguchi, N., J. Katayama, and K. O'Hara. 1996. Cloning and nucleotide sequence of the mphB gene for macrolide 2'-phosphotransferase II in Escherichia coli. FEMS Microbiol Lett. 144:197-202[Medline]. |
| 18. |
Nucifora, G.,
L. Chu,
T. K. Misra, and S. Silver.
1989.
Cadmium resistance from Staphylococcus aureus plasmid pI258 cadA gene results from a cadmium-efflux ATPase.
Proc. Natl. Acad. Sci. USA
86:3544-3548 |
| 19. |
Paton, R.,
R. S. Miles, and S. G. Amyes.
1994.
Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia.
Antimicrob. Agents Chemother.
38:2143-2149 |
| 20. |
Paulsen, I. T.,
M. H. Brown, and R. A. Skurray.
1998.
Characterization of the earliest known Staphylococcus aureus plasmid encoding a multidrug efflux system.
J. Bacteriol.
180:3477-3479 |
| 21. | Penzak, S. R., and B. J. Abate. 1997. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen. Pharmacotherapy 17:293-301[Medline]. |
| 22. |
Perelle, S.,
M. Gibert,
P. Boquet, and M. R. Popoff.
1993.
Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli.
Infect. Immun.
61:5147-5156 |
| 23. | Quinn, J. P. 1998. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin. Infect. Dis. 27:S117-S124. |
| 24. |
Rice, L. B., and L. L. Carias.
1998.
Transfer of Tn5385, a composite, multiresistance chromosomal element from Enterococcus faecalis.
J. Bacteriol.
180:714-721 |
| 25. | Rowland, S. J., and K. G. Dyke. 1989. Characterization of the staphylococcal beta-lactamase transposon Tn552. EMBO J. 8:2761-2773[Medline]. |
| 26. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 27. |
Sanschagrin, F.,
J. Dufresne, and R. C. Levesque.
1998.
Molecular heterogeneity of the L-1 metallo-beta-lactamase family from Stenotrophomonas maltophilia.
Antimicrob. Agents Chemother.
42:1245-1248 |
| 28. |
Tenover, F. C.,
R. Arbeit,
G. Archer,
J. Biddle,
S. Byrne,
R. Goering,
G. Hancock,
G. A. Hebert,
B. Hill, and R. Hollis.
1994.
Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus.
J. Clin. Microbiol.
32:407-415 |
| 29. | Walsh, T. R., A. P. MacGowan, and P. M. Bennett. 1997. Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41:1460-1464[Abstract]. |
| 30. | Walsh, T. R., L. Hall, S. J. Assinder, W. W. Nichols, S. J. Cartwright, A. P. MacGowan, and P. M. Bennett. 1994. Sequence analysis of the L1 metallo-beta-lactamase from Xanthomonas maltophilia. Biochim. Biophys. Acta 1218:199-201[Medline]. |
| 31. | Yamazaki, E., J. Ishii, K. Sato, and T. Nakae. 1989. The barrier function of the outer membrane of Pseudomonas maltophilia in the diffusion of saccharides and beta-lactam antibiotics. FEMS Microbiol. Lett. 51:85-88[Medline]. |
| 32. |
Yoon, K. P.,
T. K. Misra, and S. Silver.
1991.
Regulation of the cadA cadmium resistance determinant of Staphylococcus aureus plasmid pI258.
J. Bacteriol.
173:7643-7649 |
| 33. |
Zhang, L.,
X. Z. Li, and K. Poole.
2000.
Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.
Antimicrob. Agents Chemother.
44:287-293 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |